STADA Arzneimittel AG (STAGn.DE)
FRANKFURT, Feb 1 Stada on Thursday named Peter Goldschmidt to take over as chief executive from Sept. 1, replacing Claudio Albrecht after less than a year in office.
* TO APPOINT NOVARTIS EXECUTIVE PETER GOLDSCHMIDT AS NEW CEO - REPORT BY APOTHEKE ADHOC
* STADA AGREES TO EARLY TERMINATION OF LICENSE AGREEMENT WITH SANOFI FOR HEAD LICE LOTION HEDRIN Further company coverage: (Gdynia Newsroom)
* DOMINATION AND PROFIT AND LOSS TRANSFER AGREEMENT PURSUANT TO SECTIONS 291 ET SEQQ. AKTG CONCLUDED BETWEEN STADA ARZNEIMITTEL AG AND NIDDA HEALTHCARE GMBH
LONDON/FRANKFURT Swiss food giant Nestle and the private equity owners of German drug firm Stada are both preparing tentative bids for Merck KgaA's consumer health unit, several sources told Reuters.
* CEO says are confident that a profit and domination agreement with Elliott can be concluded at an EGM in Q1 2018 Further company coverage:
* dgap-news: bain capital and cinven announce appointment of five new supervisory board members at stada Source text for Eikon: Further company coverage: (Frankfurt newsroom)
* dgap-adhoc: stada arzneimittel ag: supervisory board of stada arzneimittel ag elects dr. Günter von au as new chairman Source text for Eikon: Further company coverage: (Frankfurt newsroom)
* Says external law firm’s investigation of certain former execs didn't find evidence of self-enrichment, bribery or other criminal activity